Pure Global AI
ANVISA registration 10287411753Active

Immunoglobulin Negative Control (Primary Antibody)

ANVISA Registration Number: 10287411753ROCHE DIAGNÓSTICA BRASIL LTDAVENTANA MEDICAL SYSTEM, INCRisk Class II
Verified
Device names
Technical name
Immunoglobulin Negative Control (Primary Antibody)
View exact technical-name matches →
PT: CONTROLE NEGATIVO DE IMUNOGLOBULINA (ANTICORPO PRIMÁRIO)
Commercial name
Rabbit Monoclonal Negative Control Ig
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
10287411753
Process Number
25351114446202528
CNPJ
30280358000186
Company information
Registration Holder
ROCHE DIAGNÓSTICA BRASIL LTDA
Manufacturer
VENTANA MEDICAL SYSTEM, INC
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Jul 28, 2025
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for Immunoglobulin Negative Control (Primary Antibody) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411753 and manufactured by VENTANA MEDICAL SYSTEM, INC. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.